Skip to main content
Ainos, Inc.SEC 8-K

Ainos signs global licensing deal for VELDONA® platform, securing $600K upfront and up to $10M.

What happened

3 signals in this filing. Ainos is monetizing its VELDONA® technology platform through a worldwide exclusive license, generating immediate non-dilutive funding. This partnership creates operational complexity around technology transfer...

Source

Extracted by Autobound

From the Signal API record
Signal
SEC 8-K

What this signalsFilings often name leadership changes, deals and spending plans.

Filed
Sep 28, 2026

The full record

From the Signal API record

Numbers

Dollar figureupfront license fee from BioPhoenix Co., Ltd.
$600K
Percentof BioPhoenix’s net sublicensing revenue for the Licensed Indications
0.25%

Details

CIK
1014763
Accession number
0001493152-26-044454
Timeframe
Immediate
Filing year
2026
Why it matters
Vendor relationship signal
Signal category
Strategic

Topics and mentions

Regions named

  • worldwide
  • Taiwan

Technologies named

  • VELDONA®
  • interferon alpha

Extraction

Confidence
High
Relevance
90%
Sentiment
Positive
Detected
Sep 29, 2026
signal_type
sec-8k
signal_subtype
materialContract

Use this data

Get every SEC 8-K signal for Ainos, Inc. and the companies you sell to, in the tools you already use.

  1. Ask Claude about it

    Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at Ainos, Inc. this week?”

  2. Send it to your own tools

    The Signal API returns SEC 8-K signals for any list of companies as JSON, for your CRM, warehouse or app.

  3. Try it free

    Sign up and spend your free credits on the companies you sell to.

    Start Free1,000 free credits

The API returns more than this page shows

This page shows a preview. The full sec-8k record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.

Company

  • linkedin_urlValue in the API
  • industriesValue in the API
  • employee_count_lowValue in the API
  • employee_count_highValue in the API
  • revenueValue in the API
  • descriptionValue in the API

Signal

  • signal_nameValue in the API
  • associationValue in the API
Show the full JSONThe record on this page and the API request

GET /v1/signals/b9e5201b-5d3e-4bc8-be02-867daa6a6c8b returns this record as JSON. POST /v1/companies/enrich returns every signal for ainos.com.

{
  "signal_id": "b9e5201b-5d3e-4bc8-be02-867daa6a6c8b",
  "signal_type": "sec-8k",
  "signal_subtype": "materialContract",
  "detected_at": "2026-09-29T08:08:40.717+00:00",
  "company": {
    "name": "Ainos, Inc.",
    "domain": "ainos.com"
  },
  "data": {
    "detail": "Ainos is monetizing its VELDONA® technology platform through a worldwide exclusive license, generating immediate non-dilutive funding. This partnership creates operational complexity around technology transfer, royalty management, and compliance, potentially opening needs for related software and services.",
    "metrics": {
      "pct": 0.25,
      "timeframe": "immediate",
      "pct_context": "of BioPhoenix’s net sublicensing revenue for the Licensed Indications",
      "dollar_context": "upfront license fee from BioPhoenix Co., Ltd.",
      "dollar_millions": 0.6
    },
    "summary": "Ainos signs global licensing deal for VELDONA® platform, securing $600K upfront and up to $10M.",
    "relevance": 0.9,
    "sentiment": "positive",
    "confidence": "high",
    "source_url": "https://www.sec.gov/Archives/edgar/data/1014763/000149315226044454/form8-k.htm",
    "filing_date": "2026-09-28",
    "filing_year": 2026,
    "sales_relevance": "Vendor relationship signal",
    "signal_category": "strategic",
    "regions_mentioned": [
      "worldwide",
      "Taiwan"
    ],
    "technologies_mentioned": [
      "VELDONA®",
      "interferon alpha"
    ]
  }
}

Long text fields are shortened on this page.

Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.